The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000527.5(LDLR):c.1976C>A (p.Thr659Asn)

CA10585704

252141 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 9949e5e8-d117-4913-a756-ec01893ced1c
Approved on: 2023-03-20
Published on: 2023-03-31

HGVS expressions

NM_000527.5:c.1976C>A
NM_000527.5(LDLR):c.1976C>A (p.Thr659Asn)
NC_000019.10:g.11120222C>A
CM000681.2:g.11120222C>A
NC_000019.9:g.11230898C>A
CM000681.1:g.11230898C>A
NC_000019.8:g.11091898C>A
NG_009060.1:g.35842C>A
ENST00000558518.6:c.1976C>A
ENST00000252444.9:n.2230C>A
ENST00000455727.6:c.1472C>A
ENST00000535915.5:c.1853C>A
ENST00000545707.5:c.1595C>A
ENST00000557933.5:c.1976C>A
ENST00000558013.5:c.1976C>A
ENST00000558518.5:c.1976C>A
ENST00000559340.1:n.557C>A
NM_000527.4:c.1976C>A
NM_001195798.1:c.1976C>A
NM_001195799.1:c.1853C>A
NM_001195800.1:c.1472C>A
NM_001195803.1:c.1595C>A
NM_001195798.2:c.1976C>A
NM_001195799.2:c.1853C>A
NM_001195800.2:c.1472C>A
NM_001195803.2:c.1595C>A
More

Uncertain Significance

Met criteria codes 2
PM2 BS3
Not Met criteria codes 20
PM6 PS2 PS4 PS3 PS1 PM3 PM1 PM4 PM5 BA1 PP4 PP1 PP3 PVS1 BS2 BS4 BS1 BP7 BP2 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1976C>A (p.Thr659Asn) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence codes (PM2, BS3) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1101/2021.03.17.21252755). The supporting evidence is as follows: PM2 - PopMax MAF = 0.00002413 (0.002413%) in African/African American genomes (gnomAD v3.1.2). BS3 - Level 1 assays: PMID 32015373: Heterologous cells, FACS assays - result - 96% cell surface LDLR, 99% LDL-LDLR binding and 97% uptake. ---- functional study is consistent with no damaging effect.
Met criteria codes
PM2
PopMax MAF = 0.00002413 (0.002413%) in African/African American genomes (gnomAD v3.1.2), so PM2 is Met.
BS3
Level 1 assays: PMID 32015373: Heterologous cells, FACS assays - result - 96% cell surface LDLR, 99% LDL-LDLR binding and 97% uptake. ---- functional study is consistent with no damaging effect, so BS3 is Met.
Not Met criteria codes
PM6
de novo occurrence data not reported, so PM6 is Not Met.
PS2
de novo occurrence data not reported, so PS2 is Not Met.
PS4
Variant meets PM2, but case data not reported, so PS4 is Not Met.
PS3
Level 1 assays: PMID 32015373: Heterologous cells, FACS assays - result - 96% cell surface LDLR, 99% LDL-LDLR binding and 97% uptake. ---- functional study is consistent with no damaging effect, so PS3 is not met.
PS1
No more missense variants that lead to the same amino acid change, so PS1 is Not Met.
PM3
Not observed in trans with other LP/P variants, so PM3 is Not Met.
PM1
Variant meets PM2 but is not located in exon 4 or alters a cysteine residues, so PM1 is Not Met.
PM4
Variant meets PM2 and is missense, so PM4 is Not Met.
PM5
1 other missense variant in the same codon: - NM_000527.5(LDLR):c.1975A>C (p.Thr659Pro)(ClinVar ID: 252140) - Uncertain significance - insufficient evidence by these guidelines There are no more variants in the same codon classified as Pathogenic by these guidelines.
BA1
No FAF, just total MAF = 0.000006571 (0.0006571%) genomes (gnomAD v3.1.2), so BA1 is not met.
PP4
Variant meets PM2 but phenotype data is not reported, so PP4 is Not Met.
PP1
Segregation data not reported, so PP1 is Not Met.
PP3
REVEL = 0.707. It is not above 0.75, splicing evaluation needed. Functional data on splicing not available. A) variant not on limits. B) variant is exonic and at least 50bp downstream from the canonical acceptor site, but it does not create GT. C) there is no a GT nearby. --- PP3 is not met.
PVS1
Variant is missense, so PVS1 is Not Met.
BS2
Case-control data not reported, so BS2 is Not Met.
BS4
Lack of segregation data not reported, so BS4 is Not Met.
BS1
No FAF, just total MAF = 0.000006571 (0.0006571%) genomes (gnomAD v3.1.2), so BA1 is not met.
BP7
Variant is not synonymous, so BP7 is Not Met.
BP2
Not observed in trans with other LP/P variants, so BP2 is Not Met.
BP4
REVEL = 0.707. It is not below 0.50, so BP4 is Not Met.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.